Point72 Hong Kong LTD Iovance Biotherapeutics, Inc. Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $197,337 - $271,468	20,707 New	20,707 $198,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $67,990 - $104,897	-5,492 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $73,498 - $122,704	4,441 Added 422.55%	5,492 $105,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $814,386 - $1.07 Million	-40,019 Reduced 97.44%	1,051 $26,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $670,673 - $1.36 Million	41,070 New	41,070 $1.07 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $110,889 - $145,054	-3,996 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $108,731 - $163,836	3,996 New	3,996 $110,000
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $484 - $794	-27 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $10,614 - $15,340	-590 Reduced 95.62%	27 $0
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $13,711 - $34,377	-1,402 Reduced 69.44%	617 $15,000
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $16,979 - $22,733	2,019 New	2,019 $19,000
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $24,850 - $33,832	-1,996 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $16,167 - $38,922	1,996 New	1,996 $34,000

339

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $877M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.